MSI status plus immunoscore to select metastatic colorectal cancer patients for immunotherapies
Galon J, Mlecnik B, Hermitte F, Marliot F, Bifulco C, Lugli A, Nagtegaal ID, Hartmann A, Van Den Eynde M, Roehrl M, Ohashi P, Zavadova E, Torigoe T, Patel P, Wang Y, Kawakami Y, Marincola FM, Ascierto PA, Fox B, Pages F (2018)
Publication Type: Conference contribution
Publication year: 2018
Journal
Publisher: OXFORD UNIV PRESS
City/Town: OXFORD
Conference Proceedings Title: ANNALS OF ONCOLOGY
Event location: Geneva
DOI: 10.1093/annonc/mdy493.011
Authors with CRIS profile
Involved external institutions
Providence Portland Medical Center
United States (USA) (US)
Georges Pompidou European Hospital / Hôpital Européen Georges-Pompidou (HEGP)
France (FR)
AbbVie Deutschland GmbH & Co. KG
Germany (DE)
Keio University / 慶應義塾大学
Japan (JP)
Earle A. Chiles Research Institute at the Robert W. Franz Cancer Center
United States (USA) (US)
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
Italy (IT)
Xi’an Jiaotong-Liverpool University (XJTLU)
China (CN)
Memorial Sloan Kettering Cancer Center
United States (USA) (US)
National Institute for Health and Medical Research / Institut national de la santé et de la recherche médicale (INSERM)
France (FR)
HalioDx - Luminy Biotech Entreprises
France (FR)
University Health Network (UHN)
Canada (CA)
Sapporo Medical University / 札幌医科大学
Japan (JP)
Gujarat Cancer & Research Institute
India (IN)
Univerzita Karlova v Praze / Charles University in Prague
Czech Republic (CZ)
Cliniques universitaires Saint-Luc (CHU St-Luc)
Belgium (BE)
Inselspital, Universitätsspital Bern
Switzerland (CH)
Radboud University Nijmegen
Netherlands (NL)
United States (USA) (US)
Georges Pompidou European Hospital / Hôpital Européen Georges-Pompidou (HEGP)
France (FR)
AbbVie Deutschland GmbH & Co. KG
Germany (DE)
Keio University / 慶應義塾大学
Japan (JP)
Earle A. Chiles Research Institute at the Robert W. Franz Cancer Center
United States (USA) (US)
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
Italy (IT)
Xi’an Jiaotong-Liverpool University (XJTLU)
China (CN)
Memorial Sloan Kettering Cancer Center
United States (USA) (US)
National Institute for Health and Medical Research / Institut national de la santé et de la recherche médicale (INSERM)
France (FR)
HalioDx - Luminy Biotech Entreprises
France (FR)
University Health Network (UHN)
Canada (CA)
Sapporo Medical University / 札幌医科大学
Japan (JP)
Gujarat Cancer & Research Institute
India (IN)
Univerzita Karlova v Praze / Charles University in Prague
Czech Republic (CZ)
Cliniques universitaires Saint-Luc (CHU St-Luc)
Belgium (BE)
Inselspital, Universitätsspital Bern
Switzerland (CH)
Radboud University Nijmegen
Netherlands (NL)
How to cite
APA:
Galon, J., Mlecnik, B., Hermitte, F., Marliot, F., Bifulco, C., Lugli, A.,... Pages, F. (2018). MSI status plus immunoscore to select metastatic colorectal cancer patients for immunotherapies. In ANNALS OF ONCOLOGY. Geneva, CH: OXFORD: OXFORD UNIV PRESS.
MLA:
Galon, J., et al. "MSI status plus immunoscore to select metastatic colorectal cancer patients for immunotherapies." Proceedings of the ESMO Immuno-Oncology Congress, Geneva OXFORD: OXFORD UNIV PRESS, 2018.
BibTeX: Download